CD133, One of the Markers of Cancer Stem Cells in Hep‐2 Cell Line
Liang Zhou(Eye & ENT Hospital of Fudan University), Jack J. Jiang(Stony Brook University), Jie Tian(University of Science and Technology of China), Lei Cheng(Fudan University), Xudong Wei(Zhengzhou University)
Cited by 125
Related Papers
Reversibly Switching Bilayer Permeability and Release Modules of Photochromic Polymersomes Stabilized by Cooperative Noncovalent Interactions
|Journal of the American Chemical Society|2015|293
In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep‐2 cell line
|Head & Neck|2008|92
Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain
|Cancer Letters|2013|75
In vivo synthesis of nano-selenium by Tetrahymena thermophila SB210
|Enzyme and Microbial Technology|2016|55
Characterization of side population cells from laryngeal cancer cell lines
|Head & Neck|2010|51